Revvity's Dharmacon All-in-one lentiviral platform has expanded to include whole-genome library options for CRISPR knockout (CRISPRko), CRISPR interference (CRISPRi), and CRISPR activation (CRISPRa).
Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases In biology’s standard tale of two acids — deoxyribonucleic (DNA) ...
JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, ...
Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and ...
Fibroblast-activating protein (FAP) expression and first clinical utility of 68Ga-FAPI-PET-CT in testicular cancer patients. Real world data: Survival outcomes of patients with poor prognosis ...
More than 10 million people develop tuberculosis (TB) each year, yet about 40% go undiagnosed. The main culprit is reliance on sputum-based testing, which many patients—particularly those who are ...
The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide. This prevalent condition is also linked to other metabolic disorders, including type 2 ...
Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based ...
Scientists design therapeutic approaches for cancer around mutations and variations that affect disease onset and progression. However, these determinants can differ across populations, and what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results